US2017112574A1PendingUtilityA1

Use of fractional emr technology on incisions and internal tissues

Assignee: PALOMAR MEDICAL TECH LLCPriority: Apr 9, 2004Filed: Jan 9, 2017Published: Apr 27, 2017
Est. expiryApr 9, 2024(expired)· nominal 20-yr term from priority
A61B 2018/00559A61B 18/22A61B 18/24A61B 2018/00642A61B 2018/0047A61B 2018/00488A61B 2018/00452A61B 18/203A61B 2018/00589A61B 2018/00577A61B 2018/00005A61B 2018/2261A61B 2018/00327
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of treatment of tissue with electromagnetic radiation (EMR) to produce lattices of EMR-treated islets in the tissue are disclosed. Specifically, methods of treating internal hard and soft tissues, such as but not limited to organs, bones, muscles, tendons, ligaments, vessels and nerves, with such EMR-treated islets are described. Also disclosed are devices and systems for producing lattices of EMR-treated islets in tissue, and cosmetic and medical applications of such devices and systems.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A device for performing a treatment on a volume of internal tissue, including:
 a source of treatment radiation;   a tube configured for insertion into a lumen of an internal tissue, the tube comprising a plurality of windows, wherein disposing said tube on an end of the source of treatment radiation creates an optical system to which treatment radiation from said source is applied, said optical system providing a plurality of separated beams of treatment radiation to at least one depth in said volume of internal tissue and to selected areas of said volume, said at least one depth and said areas defining three dimensional damaged portions in said volume within spared portions of said volume.   
     
     
         2 . The device of  claim 1 , wherein the internal tissue is accessed by an orifice of a body cavity. 
     
     
         3 . The device of  claim 1 , wherein the internal tissue is esophageal tissue. 
     
     
         4 . The device of  claim 1 , wherein the damaged portions are formed substantially serially. 
     
     
         5 . The device of  claim 1 , wherein said source of treatment radiation comprises an optical fiber. 
     
     
         6 . A method for performing a treatment on a volume located at area and depth coordinates of an internal tissue of a patient including:
 inserting into a lumen internal to a body a tube of a treatment device comprising an optical system providing multiple foci for concentrating treatment radiation to at least one depth within said depth coordinate and to selected areas within said area coordinates of said volume; and   utilizing said optical system to apply the treatment radiation to said selected areas such that following application of the treatment radiation three dimensionally located damaged tissue portions are formed in said volume separated from one another by spared portions of said volume.   
     
     
         7 . The method of  claim 6 , wherein the lumen is accessed by an orifice of a body cavity. 
     
     
         8 . The method of  claim 6 , wherein the internal tissue is esophageal tissue. 
     
     
         9 . The method of  claim 6 , wherein the internal tissue is mucosal tissue. 
     
     
         10 . The method of  claim 6 , wherein the internal tissue is vaginal tissue. 
     
     
         11 . The method of  claim 6 , wherein damaged tissue is coagulated. 
     
     
         12 . The method of  claim 6 , wherein said optical system applies treatment radiation serially. 
     
     
         13 . The method of  claim 6 , wherein damaged tissue is ablated. 
     
     
         14 . The method of  claim 13 , wherein the ablated tissue portions exhibit a fill factor in a range from about 0.1% to about 90%. 
     
     
         15 . The method of  claim 13 , wherein the ablated tissue portions exhibit a fill factor in a range from about 10% to about 50%. 
     
     
         16 . The method of  claim 13 , wherein the ablated tissue portions exhibit a fill factor in a range from about 10% to about 30%. 
     
     
         17 . The method of  claim 13 , wherein the ablated tissue portions comprise microzones of ablated tissue.

Join the waitlist — get patent alerts

Track US2017112574A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.